Skip to main content
Log in

Ultrasonography in the diagnosis of complications in patients with portal hypertension

  • Special Feature: Review Article
  • Imaging-based diagnosis and management of cirrhosis/portal hypertension
  • Published:
Journal of Medical Ultrasonics Aims and scope Submit manuscript

Abstract

This review focuses on ultrasonography (US) to diagnose patients with complications in portal hypertension. Clinicians first use US to evaluate patients with suspected portal hypertension, because US is quick, simple, and radiation free. US is necessary for grading and performing paracentesis for ascites. Doppler US-based detection of reverse splanchnic vein flow or the presence of a spontaneous portosystemic shunt is highly specific in patients with cirrhosis. Since it is important to estimate spleen size in patients with portal hypertension, spleen size is usually measured by US. Spleen volume can be more accurately measured with 3D-US. Estimation of viable residual splenic volume after partial splenic embolization should be limited to cases with total splenic volume less than 1000 ml. Portal vein thrombosis is often detected during the US examination performed when symptoms first appear or during the follow-up. Two-dimensional transthoracic echocardiography is an excellent noninvasive screening test in patients with pulmonary portal hypertension who can undergo it. By measuring the maximum and minimum diastolic blood flow velocities in the renal arteries using renal color Doppler US, the pulsatility index (PI) and resistive index (RI) can be calculated. The PI and RI in cirrhotic patients were significantly higher than those in healthy subjects and patients with chronic hepatitis, and showed a significant positive correlation with the Child–Pugh Score. In conclusion, US is an essential tool for the diagnosis and treatment of patients with portal hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

Abbreviations

US:

Ultrasonography

CE-US:

Contrast-enhanced US

PS:

Portosystemic shunts

PVT:

Portal vein thrombosis

PVTT:

Portal venous tumor thrombosis

HVPG:

Hepatic venous pressure gradient

CSPH:

Clinically significant portal hypertension

PoPH:

Pulmonary portal hypertension

HRS:

Hepatorenal syndrome

SBP:

Spontaneous bacterial peritonitis

UVSs:

Umbilical vein shunts

MSs:

Mesenteric shunts

CT:

Computed tomography

SI:

Splenic index

VOCAL:

Virtual organ computer-aided analysis

ICCs:

Interclass correlation coefficients

PSE:

Partial splenic embolization

RHC:

Right-sided heart catheterization

TTE:

Transthoracic echocardiography

RVSP:

Right-ventricular systolic pressure

PASP:

Pulmonary artery systolic pressure

PI:

Pulsatility index

RI:

Resistive index

BUN:

Blood urea nitrogen

Cr:

Creatinine

References

  1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406–60.

    Article  Google Scholar 

  2. Ginés P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:122–8.

    Article  PubMed  Google Scholar 

  3. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38:258–66.

    Article  PubMed  Google Scholar 

  4. Lin CH, Shih FY, Ma MHM, et al. Should bleeding tendency deter abdominal paracentesis? Dig Liver Dis. 2005;37:946–51.

    Article  PubMed  Google Scholar 

  5. Park SW, Ko SY, Yoon SY, et al. Transcatheter arterial embolization for hemoperitoneum: unusual manifestation of iatrogenic injury to abdominal muscular arteries. Abdom Imaging. 2011;36:74–8.

    Article  PubMed  Google Scholar 

  6. Lipinski M, Saborowski M, Heidrich B, et al. Clinical characteristics of patients with liver cirrhosis and spontaneous portosystemic shunts detected by ultrasound in a tertiary care and transplantation center. Scand J Gastroenterol. 2018;53:1107–13.

    Article  PubMed  Google Scholar 

  7. Martínez-Noguera A, Montserrat E, Torrubia S, et al. Doppler in hepatic cirrhosis and chronic hepatitis. Semin Ultrasound CT MR. 2002;23:19–36.

    Article  PubMed  Google Scholar 

  8. Procopet B, Berzigotti A. Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep. 2017;5:79–89.

    Article  Google Scholar 

  9. Simón-Talero M, Roccarina D, Martínez J, et al. Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis. Gastroenterology. 2018;154:1694–705.

    Article  PubMed  Google Scholar 

  10. Dömland M, Gebel M, Caselitz M, et al. Comparison of portal venous flow in cirrhotic patients with and without paraumbilical vein patency using duplex-sonography. Ultraschall Med. 2000;21:165–9.

    Article  PubMed  Google Scholar 

  11. von Herbay A, Frieling T, Häussinger D. Color Doppler sonographic evaluation of spontaneous portosystemic shunts and inversion of portal venous flow in patients with cirrhosis. J Clin Ultrasound. 2000;28:332–9.

    Article  Google Scholar 

  12. Zardi EM, Uwechie V, Caccavo D, et al. Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance. J Gastroenterol. 2009;44:76–83.

    Article  PubMed  Google Scholar 

  13. Riehl J, Bongartz D, Nguyen H, et al. Spontaneous portasystemic shunt in liver cirrhosis: imaging with color-coded duplex ultrasonography. Ultraschall Med. 1997;18:272–6.

    Article  CAS  PubMed  Google Scholar 

  14. Sie A, Johnson MB, Lee KP, et al. Color Doppler sonography in spontaneous splenorenal portosystemic shunts. J Ultrasound Med. 1991;10:167–9.

    Article  CAS  PubMed  Google Scholar 

  15. Ohira M, Ishifuro M, Ide K, et al. Significant correlation between spleen volume and thrombocytopenia in liver transplant patients: a concept for predicting persistent thrombocytopenia. Liver Transpl. 2009;15:208–15.

    Article  PubMed  Google Scholar 

  16. Pockros PJ, Duchini A, McMillan R, et al. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 2002;97:2040–5.

    Article  PubMed  Google Scholar 

  17. Nagamine T, Ohtuka T, Takehara K, et al. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol. 1996;24:135–40.

    Article  CAS  PubMed  Google Scholar 

  18. Peck-Radosavljevic M, Wichlas M, Zacherl J, et al. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood. 2000;95:795–801.

    Article  CAS  PubMed  Google Scholar 

  19. Yang JC, Rickman LS, Bosser SK. The clinical diagnosis of splenomegaly. West J Med. 1991;155:47–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Ishibashi H, Higuchi N, Shimamura R, et al. Sonographic assessment and grading of spleen size. J Clin Ultrasound. 1991;19:21–5.

    Article  CAS  PubMed  Google Scholar 

  21. Matsutani S, Kimura K, Ohto M, et al. Ultrasonography in the diagnosis of portal hypertension. In: Okuda K, Benhamou JP, editors., et al., Portal hypertension clinical and physiological aspects. Tokyo: Springer-Verlag; 1991. p. 197–206.

    Chapter  Google Scholar 

  22. Sheth SG, Mani S, Tamhankar H, et al. Spleen size in health and disease: a sonographic assessment. J Assoc Physicians India. 1995;43:182–4.

    CAS  PubMed  Google Scholar 

  23. Hidaka H, Nakazawa T, Wang G, et al. Reliability and validity of splenic volume measurement by 3-D ultrasound. Hepatol Res. 2010;40:979–88.

    Article  PubMed  Google Scholar 

  24. Maddison FE. Embolic therapy of hypersplenism. Invest Radiol. 1973;8:280–1.

    Article  Google Scholar 

  25. Yoshida H, Mamada Y, Taniai N, et al. Partial splenic embolization. Hepatol Res. 2008;38:225–33.

    Article  PubMed  Google Scholar 

  26. Hayashi H, Beppu T, Okabe K, et al. Therapeutic factor considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis. J Gastroenterol. 2010;45:554–9.

    Article  PubMed  Google Scholar 

  27. Hayashi H, Beppu T, Okabe K, et al. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg. 2008;95:744–50.

    Article  CAS  PubMed  Google Scholar 

  28. Schlesinger AE, Edgar KA, Boxer LA. Volume of the spleen in children as measured on CT scans: normal standards as a function of body weight. Am J Roentgenol. 1993;160:1107–9.

    Article  CAS  Google Scholar 

  29. Breiman RS, Beck JW, Korobkin M, et al. Volume determinations using computed tomography. Am J Roentgenol. 1982;138:329–33.

    Article  CAS  Google Scholar 

  30. Lamb PM, Lund A, Kanagasabay RR, et al. Spleen size: how well do linear ultrasound measurements correlate with three-dimensional CT volume assessments? Br J Radiol. 2002;75:573–7.

    Article  CAS  PubMed  Google Scholar 

  31. Hidaka H, Wang G, Nakazawa T, et al. Total and viable residual splenic volume measurement after partial splenic embolization by three-dimensional ultrasound. J Med Ultrason. 2013;40:417–24.

    Article  Google Scholar 

  32. Kawanaka H, Akahoshi T, Kinjo N, et al. Laparoscopic splenectomy with technical standardization and selection criteria for standard or hand-assisted approach in 390 patients with liver cirrhosis and portal hypertension. J Am Coll Surg. 2015;221:354–66.

    Article  PubMed  Google Scholar 

  33. Mahon D, Rhodes M. Laparoscopic splenectomy: size matters. Ann R Coll Surg Engl. 2003;85:248–51.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Patel AG, Parker JE, Wallwork B, et al. Massive splenomegaly is associated with significant morbidity after laparoscopic splenectomy. Ann Surg. 2003;238:235–40.

    PubMed  PubMed Central  Google Scholar 

  35. Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;73:366–413.

    Article  PubMed  Google Scholar 

  36. Lisman T, Kamphuisen PW, Northup PG, et al. Established and new-generation antithrombotic drugs in patients with cirrhosis—possibilities and caveats. J Hepatol. 2013;59:358–66.

    Article  CAS  PubMed  Google Scholar 

  37. Maruyama H, Ishibashi H, Takahashi M, et al. Prediction of the therapeutic effects of anticoagulation for recent portal vein thrombosis: a novel approach with contrast-enhanced ultrasound. Abdom Imaging. 2012;37:431–8.

    Article  PubMed  Google Scholar 

  38. Lv Y, Han G, Fan D. Portopulmonary hypertension. Scand J Gastroenterol. 2016;51:795–806.

    Article  CAS  PubMed  Google Scholar 

  39. Krowka MJ, Swanson KL, Frantz RP. Portopulmonary hypertension: Results from a 10-year screening algorithm. Hepatology. 2006;44:1502–10.

    Article  PubMed  Google Scholar 

  40. Raevens S, Colle I, Reyntjens K, et al. Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values. Liver Transpl. 2013;19:602–10.

    Article  PubMed  Google Scholar 

  41. Cotton CL, Gandhi S, Vaitkus PT, et al. Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates. Liver Transpl. 2002;8:1051–4.

    Article  PubMed  Google Scholar 

  42. Colle I. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003;37:401–9.

    Article  PubMed  Google Scholar 

  43. Kim WR, Krowka MJ, Plevak DJ, et al. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl. 2000;6:453–8.

    Article  PubMed  Google Scholar 

  44. Torregrosa M, Genesca J, Gonzalez A, et al. Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates. Transplantation. 2001;71:572–4.

    Article  CAS  PubMed  Google Scholar 

  45. Hua R, Sun YW, Wu ZY, et al. Role of 2-dimensional Doppler echo-cardiography in screening portopulmonary hypertension in portal hypertension patients. Hepatobiliary Pancreat Dis Int. 2009;8:157–61.

    PubMed  Google Scholar 

  46. Auletta M, Oliviero U, Iasiuolo L, et al. Pulmonary hypertension associated with liver cirrhosis: an echocardiographic study. Angiology. 2000;51:1013–20.

    Article  CAS  PubMed  Google Scholar 

  47. Ko JM, Ahn MI, Han DH, et al. Dynamic CT and MRA findings of a case of portopulmonary venous anastomosis (PPVA) in a patient with portal hypertension: a case report and review of the literature. Acta Radiol. 2011;52:566–9.

    Article  PubMed  Google Scholar 

  48. Krowka MJ. Portopulmonary hypertension: diagnostic advances and caveats. Liver Transpl. 2003;9:1336–7.

    PubMed  Google Scholar 

  49. Colle IO, Moreau R, Godinho E, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003;37:401–9.

    Article  PubMed  Google Scholar 

  50. Koda M, Murawaki Y, Kawasaki H. Renovascular resistance assessed by color Doppler ultrasonography in patients with chronic liver diseases. J Gastroenterol Hepatol. 2000;15:1424–9.

    Article  CAS  PubMed  Google Scholar 

  51. Platt JF, Ellis JH, Rubin JM, et al. Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease. Hepatology. 1994;20:362–9.

    Article  CAS  PubMed  Google Scholar 

  52. Bardi A, Sapunar J, Oksenberg D, et al. Intrarenal arterial doppler ultrasonography in cirrhotic patients with ascites, with and without hepatorenal syndrome. Rev Med Chil. 2002;130:173–80.

    Article  PubMed  Google Scholar 

  53. Kastelan S, Ljubicic N, Kastelan Z, et al. The role of duplex-doppler ultrasonography in the diagnosis of renal dysfunction and hepatorenal syndrome in patients with liver cirrhosis. Hepatogastroenterology. 2004;51:1408–12.

    PubMed  Google Scholar 

Download references

Acknowledgements

We thank Hitoshi Maruyama, MD, PhD, Department of Gastroenterology, Juntendo University, for advice on writing the manuscript, and Robert E. Brandt, Founder, CEO, and CME, of MedEd Japan, for editing and formatting the manuscript.

Funding

The authors disclose no sources of funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hisashi Hidaka.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Ethical statements

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Additional informed consent was obtained from all patients for which identifying information is included in this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hidaka, H., Uojima, H. Ultrasonography in the diagnosis of complications in patients with portal hypertension. J Med Ultrasonics 49, 347–358 (2022). https://doi.org/10.1007/s10396-021-01158-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10396-021-01158-3

Keywords

Navigation